Tortoise Investment Management, LLC - ALLOGENE THERAPEUTICS INC ownership

ALLOGENE THERAPEUTICS INC's ticker is ALLO and the CUSIP is 019770106. A total of 185 filers reported holding ALLOGENE THERAPEUTICS INC in Q2 2021. The put-call ratio across all filers is 1.00 and the average weighting 0.2%.

Quarter-by-quarter ownership
Tortoise Investment Management, LLC ownership history of ALLOGENE THERAPEUTICS INC
ValueSharesWeighting
Q3 2021$16,0000.0%6280.0%0.00%0.0%
Q2 2021$16,000
-27.3%
6280.0%0.00%
-40.0%
Q1 2021$22,000
+37.5%
6280.0%0.01%
+25.0%
Q4 2020$16,000
-33.3%
6280.0%0.00%
-33.3%
Q3 2020$24,000
-11.1%
6280.0%0.01%
-14.3%
Q2 2020$27,000
+125.0%
6280.0%0.01%
+133.3%
Q1 2020$12,000
-25.0%
6280.0%0.00%
-25.0%
Q4 2019$16,000
-5.9%
6280.0%0.00%0.0%
Q3 2019$17,0006280.00%
Other shareholders
ALLOGENE THERAPEUTICS INC shareholders Q2 2021
NameSharesValueWeighting ↓
Vida Ventures Advisors, LLC 1,798,163$46,213,00013.24%
Wildcat Capital Management, LLC 1,716,370$44,111,0005.71%
TPG Group Holdings (SBS) Advisors, Inc. 18,716,306$481,009,0004.77%
Copernicus Capital Management, LLC 15,000$386,0004.67%
Coastal Bridge Advisors, LLC 301,240$7,742,0001.79%
Lombard Odier Asset Management (Switzerland) SA 914,416$23,500,0001.46%
Casdin Capital, LLC 2,100,000$53,970,0001.34%
Pier Capital, LLC 450,182$11,570,0001.20%
Ghost Tree Capital, LLC 150,000$3,855,0001.13%
Sessa Capital IM, L.P. 750,000$19,275,0000.95%
View complete list of ALLOGENE THERAPEUTICS INC shareholders